effects [qlco]
Doses [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Lipids [lipd]
Lipoprotein [aapp, bacs]
Atherogenesis [patf]
Index [inpr]
Menopausal [phsf]
Purpose [ftcn]
Study [mnob]
Make [ftcn]
Contribution [acty]
Progestagen [horm, phsu, strd]
Dose [qnco]
Women [popg]
Uterus [bpoc]
Removed [qlco]
Study [mnob]
Open [spco]
Trial [resa]
Patients [podg]
Assigned [ftcn]
Group [idcn]
Group [idcn]
N NOS [aapp, imft]
GIVEN [cnce]
mg% [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
Second [qnco]
N NOS [aapp, imft]
Mg+2 [elii, phsu]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
serum cholesterol [lbpr]
Cholesterol [bacs, strd]
Triglyceride [bacs, lipd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Low Density Lipoprotein Cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Values [qlco]
Atherogenesis [patf]
Index [inpr]
Measured [qlco]
Study [mnob]
months [tmco]
Values [qlco]
Compared [acty]
Tests [lbpr]
Group [idcn]
Unpaired t-Test [inpr]
Group [idcn]
Triglyceride level [lbtr]
Group [idcn]
Decreased [qnco]
Compared [acty]
baseline [bodm]
Addition [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Values [qlco]
Decreased [qnco]
Values [qlco]
Slightly [idcn]
Increased [qnco]
Following [tmco]
months [tmco]
Second [qnco]
Group [idcn]
Cholesterol [bacs, strd]
Triglyceride [bacs, lipd]
Atherogenesis [patf]
Index [inpr]
Decreased [qnco]
Compared [acty]
baseline [bodm]
Group [idcn]
Decrease [qlco]
statistically significant [qnco]
P NOS [aapp, imft]
Group [idcn]
P NOS [aapp, imft]
Hormone replacement therapy [topp]
Continuous [idcn]
mg% [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
2 5 [qnco]
mg/mg [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Lipid [lipd]
Profile [lbpr]
mg% [qnco]
Conjugated Equine Estrogens [horm, phsu, strd]
mg/mg [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
months [tmco]
treatment [ftcn]
